Nightingale Health receives additional regulatory approval for healthcare use from Health Sciences Authority in Singapore
Nightingale Health Plc Press release 20 August 2024 at 9:15 a.m. (EEST) Nightingale Health Plc (“Nightingale Health”), a pioneer in disease risk detection and preventative health has received additional regulatory approval from Singapore’s Health Sciences Authority (HSA), the national body that regulates medical devices, therapeutics, and other healthcare products. Nightingale Health announced earlier this year the first approval that covered the analysis of eight common clinically used biomarkers: total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides,